Skip to main content

Ebola stocks surge after first US case diagnosed

Shares of pharmaceutical companies working on a drug to treat Ebola spiked after the CDC confirmed the first case diagnosed in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.